Literature DB >> 17070543

Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.

Clara E Cases-González1, Sandra Franco, Miguel Angel Martínez, Luis Menéndez-Arias.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) strains having dipeptide insertions in the fingers subdomain and other drug resistance-related mutations scattered throughout their reverse transcriptase (RT)-coding region show high-level resistance to zidovudine (AZT) and other nucleoside analogues. Those phenotypic effects have been correlated with their increased ATP-dependent phosphorolytic activity on chain-terminated primers. Mutations T69S and T215Y and a dipeptide insertion (i.e. Ser-Ser) between positions 69 and 70 are required to achieve low-level resistance to thymidine analogues. However, additional amino acid substitutions are necessary to achieve the high-level phenotypic resistance to AZT shown by clinical HIV isolates carrying a dipeptide insertion in their RT-coding region. In order to identify those mutations that contribute to resistance in the sequence context of an insertion-containing RT derived from an HIV clinical isolate (designated as SS RT), we expressed and purified a series of chimeric enzymes containing portions of the wild-type or SS RT sequences. ATP-mediated excision activity measurements using AZT- and stavudine (d4T)-terminated primers and phenotypic assays showed that molecular determinants of high-level resistance to AZT were located in the fingers subdomain of the polymerase. Further studies, using recombinant RTs obtained by site-directed mutagenesis, revealed that M41L, A62V and in a lesser extent K70R, were the key mutations that together with T69S, T215Y and the dipeptide insertion conferred high levels of ATP-dependent phosphorolytic activity on AZT and d4T-terminated primers. Excision activity correlated well with AZT susceptibility measurements, and was consistent with phenotypic resistance to d4T. Structural analysis of the location of the implicated amino acid substitutions revealed a coordinated effect of M41L and A62V on the positioning of the beta3-beta4 hairpin loop, which plays a key role in the resistance mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070543     DOI: 10.1016/j.jmb.2006.09.073

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  In vitro cross-resistance profile of nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 against known NRTI resistance mutations.

Authors:  Zhufang Li; Brian Terry; William Olds; Tricia Protack; Carol Deminie; Beatrice Minassian; Beata Nowicka-Sans; Yongnian Sun; Ira Dicker; Carey Hwang; Max Lataillade; George J Hanna; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

2.  Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.

Authors:  Mar Álvarez; María Nevot; Jesús Mendieta; Miguel A Martínez; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2017-12-22       Impact factor: 5.157

3.  Altered strand transfer activity of a multiple-drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutant with a dipeptide fingers domain insertion.

Authors:  Laura A Nguyen; Waaqo Daddacha; Sean Rigby; Robert A Bambara; Baek Kim
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

4.  Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.

Authors:  Gilberto Betancor; Maria C Puertas; María Nevot; César Garriga; Miguel A Martínez; Javier Martinez-Picado; Luis Menéndez-Arias
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

5.  Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.

Authors:  Mónica Kisic; Tania Matamoros; María Nevot; Jesús Mendieta; Javier Martinez-Picado; Miguel A Martínez; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2011-04-19       Impact factor: 5.157

6.  Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine excision and discrimination.

Authors:  Tania Matamoros; María Nevot; Miguel Angel Martínez; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2009-09-29       Impact factor: 5.157

7.  HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate.

Authors:  Giovanni Maga; Marco Radi; Marie-Aline Gerard; Maurizio Botta; Eric Ennifar
Journal:  Viruses       Date:  2010-03-30       Impact factor: 5.818

8.  Structures of reverse transcriptase pre- and post-excision complexes shed new light on HIV-1 AZT resistance.

Authors:  Walter A Scott
Journal:  Viruses       Date:  2011-01-18       Impact factor: 5.818

9.  A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and C.

Authors:  Paul L Boyer; Catherine A Rehm; Michael C Sneller; JoAnn Mican; Margaret R Caplan; Robin Dewar; Andrea L Ferris; Patrick Clark; Adam Johnson; Frank Maldarelli; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2021-11-01       Impact factor: 5.938

Review 10.  Current perspectives on HIV-1 antiretroviral drug resistance.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Viruses       Date:  2014-10-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.